awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37486753-4BFCF6F5-A668-4F63-B298-1F141E2E431F
Q37486753-4BFCF6F5-A668-4F63-B298-1F141E2E431F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37486753-4BFCF6F5-A668-4F63-B298-1F141E2E431F
Current status of cediranib: the rapid development of a novel anti-angiogenic therapy.
P2860
Q37486753-4BFCF6F5-A668-4F63-B298-1F141E2E431F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37486753-4BFCF6F5-A668-4F63-B298-1F141E2E431F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3838e232590a0a64f0c9224564847d5919d3be2
P2860
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer